产品名称 | NebuSelect™ Recombinant Biotinylated Human LILRA1/CD85i/LIR-6, Avi-His-tag |
---|---|
目录号 | NBL-242354 |
别名 | LILRA1/CD85i/LIR-6; CD85i; LILRA1; LIR6; LIR-6; LIR6MGC126563 |
外观 | see COA |
分子量 | Pro17-Asn461 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | O75019-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242354-100ug | 100ug | Inquire | Inquire | |
NBL-242354-1mg | 1mg | Inquire | Inquire | |
NBL-242354-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Biotinylated Human LILRA1/CD85i/LIR-6, Avi-His-tag
Catalog#:
NBL-242354
Description:
NebuSelect™ Recombinant Biotinylated Human LILRA1/CD85i/LIR-6, Avi-His-tag(Cat#NBL-242354) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Pro17-Asn461.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 51.4 kDa. Due to glycosylation, the protein migrates to 70-80 kDa based on Bis-Tris PAGE result.
Target Name:
LILRA1/CD85i/LIR-6; CD85i; LILRA1; LIR6; LIR-6; LIR6MGC126563
Target Information:
LILRA1, also known as CD85i and LIR-6, is an approximately 70 kDa variably glycosylated transmembrane protein that regulates immune cell activation. Mature human LILRA1 consists of a 445 amino acid (aa) extracellular domain (ECD) with 4 Ig-like domains, a 21 aa transmembrane segment, and a 7 aa cytoplasmic tail. LILRA1 may act as receptor for class I MHC antigens.
Amino Acid Sequence:
Pro17-Asn461
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.